ArticleScientific reports2026
Magnetic BiFeO
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent Progress in the Sustainable Synthesis of Imidazole Derivatives: Advances in Multicomponent Reactions, Catalysis, and Green Chemistry.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study reports the use of magnetic bismuth ferrite, BiFeO₃, nanoparticles (BFO MNPs), as a robust and eco-friendly catalyst, for the one-pot, mild synthesis of highly substituted imidazole derivatives under solvent-free conditions, thus avoiding toxic organic solvents. The approach offers several advantages, including short reaction times, low catalyst loading, and consistently high to excellent yields with broad applicability across diverse imidazole derivatives. Furthermore, the BiFeO₃ nanocatalyst demonstrated excellent recyclability and stability, maintaining its catalytic performance over five consecutive cycles without any significant loss in its activity, thereby enabling sustainable and scalable applications. The structural and morphological properties of the synthesized BiFeO₃ nanocatalyst were thoroughly characterized using Fourier-transform infrared (FT-IR) spectroscopy, scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), EDS elemental mapping, X-ray diffraction (XRD), vibrating sample magnetometry (VSM), and Brunauer–Emmett–Teller (BET) surface area analysis. Additionally, the structures of the synthesized imidazole derivatives were confirmed by 1H NMR spectroscopy, FT-IR analysis, and melting point determination. Overall, this study highlights the potential of BiFeO₃ nanoparticles as a sustainable, high-performing, and environmentally benign catalyst, making a meaningful contribution to the advancement of green chemistry and innovative synthetic methodologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.